ATS 2021
Earlier this month, the New England Journal of Medicine released Phase 3 clinical trial results for tezepelumab - a ...
High rates of exposure to emitted printer-toner nanoparticles in the workplace has established inflammatory and ...
Physician burnout is an epidemic, with significant consequences on physician health and associations with poorer-quality ...
Treatment with velsecorat, an inhaled nonsteroidal, selective glucocorticoid receptor modulator (SGRM), improved lung ...
The P2X3 antagonist BLU-5937 reduced cough frequency during waking hours among patients with refractory chronic cough, ...
For patients with asthma, treatment with PT027, fixed-dose combination of budesonide and albuterol in a single ...
Virtual learning experiences have become widely used in all settings during the ongoing COVID-19 pandemic and are likely ...
Lower levels of vitamin D are linked with a higher rate of deaths related to COVID-19, according to researchers from the ...
Findings from a network analysis of more than one thousand patients with chronic obstructive pulmonary disease (COPD) ...
Results from a pooled analysis of two phase III randomized, controlled trials suggest that treatment with gefapixant ...
After one year of treatment with the CFTR modulators elexacaftor-tezacaftor-ivacaftor, patients with cystic fibrosis ...
Interest in at-home measurements of lung function is growing as the ongoing COVID-19 pandemic pushes more respiratory ...
In an analysis of 12-month crossover data from the AIRFLOW-2 trial, patient with chronic obstructive pulmonary disease ...
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.